Contents

Search


microvascular complication of diabetes mellitus

Pathology: 1) diabetic nephropathy 2) diabetic retinopathy 3) diabetic neuropathy Genetics: - associated with mutations in PON1 Laboratory: - PON1 gene mutation Management: - management - diabetic nephropathy - ACE inhibitor or ARB - additional agents as needed to control blood pressure - diuretic, calcium channel blocker, beta blocker - screening - diabetic nephropathy - annual serum creatinine with estimated GRR - diabetic retinopathy - ophthalmoscopy at the time of diagnosis for type 2 diabetes & within 5 years of diagnosis for type 1 diabetes & every 1-3 uthereafter - diabetic neuropathy - monofilament examination of feet annually

Specific

diabetic nephropathy; diabetic glomerulosclerosis; Kimmelstiel-Wilson disease (DMN) diabetic neuropathy diabetic retinopathy (DR, proliferative {PDR} & non-proliferative)

General

diabetes mellitus complication

References

  1. Barrett EJ, Liu Z, Khamaisi M et al Diabetic Microvascular Disease: An Endocrine Society Scientific Statement. J Clin Endocrinol Metab. 2017;102(12):4343-4410 PMID: 29126250 https://www.medscape.com/viewarticle/892224